NEW YORK (GenomeWeb News) – Fitch Ratings today affirmed BBB+ ratings for about $2.8 billion of Agilent Technologies' debt, noting the firm's ongoing revenue diversification and conservative financial policies.

Fitch issued BBB+ ratings on Agilent's issuer default rating, senior unsecured revolving credit facility, and senior unsecured notes. The ratings affect about $2.8 billion of debt, including an undrawn $400 million revolving credit facility that expires in 2016, the ratings firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.